ALLOGENEIC TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA IN THE ERA OF NOVEL THERAPIES: CHANGING INDICATIONS AND DYNAMIC RISK ASSESSMENT. Mediterr J Hematol Infect Dis 2026, 18 (1), e2026088. https://doi.org/10.4084/MJHID.2026.088.